The role of inflammation in ICU-acquired weakness
- PMID: 20727229
- PMCID: PMC2945106
- DOI: 10.1186/cc9187
The role of inflammation in ICU-acquired weakness
Abstract
A pilot observational study by Weber-Carstens and colleagues contributes to a mechanistic explanation of the puzzling and complex phenomena of ICU-acquired weakness (ICU-AW). The authors suggest systemic, inflammatory-mediated pathology is the most significant risk factor for ICU-AW. While this finding is somewhat equivocal, it provides important direction for future investigations and illustrates the challenges of interpreting significance in small observational studies.
Comment on
-
Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study.Crit Care. 2010;14(3):R119. doi: 10.1186/cc9074. Epub 2010 Jun 18. Crit Care. 2010. PMID: 20565863 Free PMC article.
References
-
- Fan E, Zanni JM, Dennison CR, Lepre SJ, Needham DM. Critical illness neuromyopathy and muscle weakness in patients in the intensive care unit. AACN Adv Crit Care. 2009;20:243–253. - PubMed
-
- Reid MB, Andrade FH, Balke CW, Esser KA. Redox mechanisms of muscle dysfunction in inflammatory disease. Phys Med Rehabil Clin N Am. 2005;16:925–949. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
